BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16772925)

  • 1. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
    Brown DL; Bishop DK; Wood SY; Cederna PS
    Plast Reconstr Surg; 2006 Jun; 117(7):2250-8. PubMed ID: 16772925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts.
    Brenner MJ; Tung TH; Mackinnon SE; Myckatyn TM; Hunter DA; Mohanakumar T
    Exp Neurol; 2004 Mar; 186(1):59-69. PubMed ID: 14980810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
    Tung TH; Mackinnon SE; Mohanakumar T
    Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
    Tung TH; Mackinnon SE; Mohanakumar T
    Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
    Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA
    Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation blockade in transplantation of nerve allografts: long-term effects.
    Kvist M; Kanje M; Ekberg H; Corbascio M; Dahlin LB
    J Peripher Nerv Syst; 2008 Sep; 13(3):200-7. PubMed ID: 18844786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.
    Mungara AK; Brown DL; Bishop DK; Wood SY; Cederna PS
    J Reconstr Microsurg; 2008 Apr; 24(3):189-95. PubMed ID: 18459087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD40 ligand antibody permits regeneration through peripheral nerve allografts in a nonhuman primate model.
    Brenner MJ; Jensen JN; Lowe JB; Myckatyn TM; Fox IK; Hunter DA; Mohanakumar T; Mackinnon SE
    Plast Reconstr Surg; 2004 Dec; 114(7):1802-14; discussion 1815-7. PubMed ID: 15577351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
    Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation by costimulation blockade inhibits rejection of nerve allografts.
    Kvist M; Lemplesis V; Kanje M; Ekberg H; Corbascio M; Dahlin LB
    J Peripher Nerv Syst; 2007 Jun; 12(2):83-90. PubMed ID: 17565532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
    Nathan MJ; Yin D; Eichwald EJ; Bishop DK
    Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
    Qian Y; Boisgerault F; Benichou G; Dana MR
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.
    Brenner MJ; Mackinnon SE; Rickman SR; Jaramillo A; Tung TH; Hunter DA; Mohanakumar T
    Restor Neurol Neurosci; 2005; 23(3-4):237-49. PubMed ID: 16082080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
    Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
    Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.
    Lal G; Nakayama Y; Sethi A; Singh AK; Burrell BE; Kulkarni N; Brinkman CC; Iwami D; Zhang T; Bromberg JS
    Transplantation; 2015 Sep; 99(9):1817-28. PubMed ID: 25839706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y; Zhou PJ; Tang XD
    Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.